BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37310469)

  • 1. Identification of a novel MSI-related ceRNA network for predicting the prognosis and immunotherapy response of gastric cancer.
    Zhang L; Cao L; Liu J; Duan L; Zhou W; Li T; Guan L; Wu X; Zhang H
    Aging (Albany NY); 2023 Jun; 15(11):5164-5189. PubMed ID: 37310469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer.
    Zhang S; Li S; Guo JL; Li N; Zhang CN; Liu J
    Dis Markers; 2021; 2021():8886897. PubMed ID: 34603561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
    Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
    J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of lncRNA-associated competing endogenous RNA networks for occurrence and prognosis of gastric carcinoma.
    Ye L; Jin W
    J Clin Lab Anal; 2021 Dec; 35(12):e24028. PubMed ID: 34704289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine.
    Chen T; Zhang C; Liu Y; Zhao Y; Lin D; Hu Y; Yu J; Li G
    BMC Genomics; 2019 Nov; 20(1):846. PubMed ID: 31722674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration.
    Zhang K; Zhang L; Mi Y; Tang Y; Ren F; Liu B; Zhang Y; Zheng P
    Cancer Sci; 2020 Nov; 111(11):4041-4050. PubMed ID: 32860283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
    Qi M; Yu B; Yu H; Li F
    Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
    Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the ferroptosis-related ceRNA network related to prognosis and tumor immunity for gastric cancer.
    Xiang Z; Zhou X; Mranda GM; Xue Y; Wang Y; Wei T; Liu J; Ding Y
    Aging (Albany NY); 2022 Jul; 14(14):5768-5782. PubMed ID: 35835721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer.
    Zhao Z; Mak TK; Shi Y; Huang H; Huo M; Zhang C
    Front Immunol; 2023; 14():1117255. PubMed ID: 37457685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immune-related ceRNA Network in Prognosis of Cervical Cancer.
    Dhandapani H; Bose M; Kesavan S
    Asian Pac J Cancer Prev; 2022 Oct; 23(10):3347-3354. PubMed ID: 36308358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis.
    Guo Y; Pan WK; Wang ZW; Su WH; Xu K; Jia H; Chen J
    Biomed Res Int; 2021; 2021():4532438. PubMed ID: 34917682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.
    Cao W; Zhou W; Li M; Zhang Z; Zhang X; Yang K; Yang S; Cao G; Chen B; Xiong M
    Front Immunol; 2022; 13():951135. PubMed ID: 36483555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
    Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
    Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer.
    Yang CZ; Hu LH; Huang ZY; Deng L; Guo W; Liu S; Xiao X; Yang HX; Lin JT; Sun LL; Lin LZ
    PLoS One; 2021; 16(12):e0260720. PubMed ID: 34855841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new risk model based on a 11-m
    Lei L; Li N; Yuan P; Liu D
    BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.